Investment Case
hVIVO is a purpose-built, full-service, expert-led international clinical development partner and the global leader in human challenge trials.
Fully integrated, end-to-end platform spanning preclinical strategy to clinical proof-of-concept.
hVIVO owns state-of-the-art, purpose-built facilities including world-class CL3 labs and quarantine units in London and clinical research sites across the UK and Germany.
hVIVO’s FluCamp platform is the largest specialist participant recruitment database in the UK and Europe combined, with over 400,000 volunteers and 100% recruitment success rate.
The Company is debt free and has Cash of c.£14.3 million as at 31 December 2025.
Well-funded to execute on its strategy to scale the business and deliver sustainable growth.
hVIVO’s end-to-end platform, which spans preclinical strategy through to clinical proof-of-concept, will ensure consistent sustainable long-term growth.
The Group has a strong sales pipeline across its four integrated, synergistic service lines, which have been built to drive cross-selling and operational leverage.
Three key targeted growth initiatives across cardiometabolic, respiratory and laboratory services.
Scalable model leveraging existing infrastructure, with limited capital requirements.
The global biopharma industry is facing increasing pressure to generate high-quality validating proof-of-concept clinical evidence faster.
Greater complexity in early-stage development is driving outsourcing to specialist partners.
Over $300bn in upcoming patent expiries is driving R&D investment and deal activity.
hVIVO offers a unique combination of international scale, proprietary infrastructure and owned clinical research sites all under one roof, that other mid-sized CRO competitors cannot replicate.
The global leader in human challenge trials with heritage dating back to the 1940s, hVIVO has unmatched operational experience and in-house expertise.
hVIVO works with seven of the 10 largest global biopharma companies.
Its trials are designed, executed and interpreted by recognised domain experts and key opinion leaders.
Holds a strong track record supporting Fast Track and Breakthrough designations and high-value M&A outcomes.
hVIVO Integrated Service Platform
Your clinical development partner
hVIVO is a full-service, early-phase clinical development partner and the global leader in human challenge trials. With integrated capabilities spanning consultancy, clinical trials, laboratory services, recruitment, and storage, the Company supports biopharma clients in accelerating development timelines and generating high-quality data. Its purpose-built facilities and expert-led approach enable efficient, end-to-end delivery across complex therapeutic areas.
Delivering trials across all phases
hVIVO delivers clinical trial services across Phase I to Phase III, supporting the progression of therapies from first-in-human studies through to later-stage development. With specialist expertise in early-phase and complex study designs, the Company provides efficient trial execution, high-quality data, and seamless integration with laboratory and recruitment capabilities to optimise outcomes and accelerate development programmes.
Strategic guidance at every stage
hVIVO’s consultancy services provide strategic and scientific guidance across the clinical development lifecycle. From regulatory strategy and trial design to due diligence and investor readiness, the team supports clients in making informed decisions at every stage. Combining deep therapeutic expertise with practical delivery experience, hVIVO helps optimise development pathways and reduce risk.
Advanced laboratory capabilities
hVIVO offers comprehensive laboratory services to support clinical trials and translational research, including bioanalytical testing, virology, immunology, and biomarker analysis. Its state-of-the-art facilities, including CL3 laboratories, enable high-quality sample processing and data generation. Fully integrated with clinical operations, these capabilities ensure consistency, speed, and scientific rigour across studies.
Decades of experience
hVIVO is the global leader in human challenge trials, with a heritage dating back decades and unmatched operational expertise. These studies involve the controlled exposure of volunteers to pathogens to generate early efficacy data, enabling faster and more cost-effective decision-making. hVIVO’s purpose-built quarantine facilities and specialist models support a wide range of infectious diseases.
Secure and compliant storage
hVIVO provides secure, compliant storage solutions for biological samples and clinical materials through its specialist cryostorage capabilities. With robust infrastructure and quality-controlled processes, the Company ensures the integrity and traceability of samples across the clinical development lifecycle. These services are fully integrated with laboratory and clinical operations for seamless handling and access.
Industry-leading recruitment
